相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Elevated HbA1c levels in pre-Covid-19 infection increases the risk of mortality: A sistematic review and meta-analysis
Francesco Prattichizzo et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2022)
The Relationship Between Diabetes Mellitus and COVID-19 Prognosis: A Retrospective Cohort Study in Wuhan, China
Jian Shang et al.
AMERICAN JOURNAL OF MEDICINE (2021)
Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story
Anca Pantea Stoian et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2021)
Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19)
Yue Zhou et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2021)
Characteristics and outcomes ofCOVID-19 in hospitalized patients with and without diabetes
Abdallah Al-Salameh et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2021)
Overexpression of the Severe Acute Respiratory Syndrome Coronavirus-2 Receptor, Angiotensin-Converting Enzyme 2, in Diabetic Kidney Disease: Implications for Kidney Injury in Novel Coronavirus Disease 2019
Richard E. Gilbert et al.
CANADIAN JOURNAL OF DIABETES (2021)
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy
S. Ciardullo et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)
Corticosteroids in diabetes patients infected with COVID-19
Fuxue Deng et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2021)
Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis
J. M. Rhodes et al.
JOURNAL OF INTERNAL MEDICINE (2021)
Pancreatic injury in the course of coronavirus disease 2019: A not-so-rare occurrence
Giuseppe Bruno et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Newly diagnosed diabetes mellitus, DKA, and COVID-19: Causality or coincidence? A report of three cases
Kulachanya Suwanwongse et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry
Francisco Javier Carrasco-Sanchez et al.
ANNALS OF MEDICINE (2021)
Effects of hyperglycaemia on complications of COVID-19: A meta-analysis of observational studies
Ming H. Lee et al.
DIABETES OBESITY & METABOLISM (2021)
COVID-19: Discovery, diagnostics and drug development
Tarik Asselah et al.
JOURNAL OF HEPATOLOGY (2021)
Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study
Ping Ling et al.
JOURNAL OF DIABETES (2021)
COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine
Shomoita Sayed
PRIMARY CARE DIABETES (2021)
SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking
Pavel Hamet et al.
AMERICAN JOURNAL OF HYPERTENSION (2021)
Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
Matteo Calcagnile et al.
BIOCHIMIE (2021)
Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients
Angelo Silverio et al.
BMC CARDIOVASCULAR DISORDERS (2021)
Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker-Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19
Sri Nagarjun Batchu et al.
DIABETES (2021)
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes
Justin M. Gregory et al.
DIABETES CARE (2021)
Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers
Osagie Ebekozien et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital
Yuhui Sun et al.
JOURNAL OF CLINICAL HYPERTENSION (2021)
COVID-19's toll on the elderly and those with diabetes mellitus - Is vitamin B12 deficiency an accomplice?
Andrew Kien Han Wee
MEDICAL HYPOTHESES (2021)
Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19
Jelena Roganovic
MEDICAL HYPOTHESES (2021)
Association between thiamine deficiency and hyperlactatemia among critically ill patients with diabetes infected by SARS-CoV-2
Sandra Elisa Adami Batista Goncalves et al.
JOURNAL OF DIABETES (2021)
Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19: Data from a multi-site surveillance registry
Kara Beliard et al.
JOURNAL OF DIABETES (2021)
Clinical Findings in Diabetes Mellitus Patients with COVID-19
Ting Guo et al.
JOURNAL OF DIABETES RESEARCH (2021)
The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus
Mao Zheng et al.
JOURNAL OF DIABETES RESEARCH (2021)
COVID-19 vaccine prioritisation for type 1 and type 2 diabetes
Alvin C Powers et al.
Lancet Diabetes & Endocrinology (2021)
Hyperosmolarity Deserves More Attention in Critically Ill COVID-19 Patients with Diabetes: A Cohort-Based Study
Luoning Gou et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2021)
Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals
Chioma Izzi-Engbeaya et al.
BMJ OPEN DIABETES RESEARCH & CARE (2021)
Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic
Merel M. Ruissen et al.
BMJ OPEN DIABETES RESEARCH & CARE (2021)
Diabetes Might Augment the Severity of COVID-19: A Current Prospects
Jayeeta Sur et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2
Noemie Zucman et al.
CLINICAL INFECTIOUS DISEASES (2021)
COVID-19 in Latin America: Symptoms, Morbidities, and Gastrointestinal Manifestations
Hassan Ashktorab et al.
GASTROENTEROLOGY (2021)
Hyperlipasemia and Potential Pancreatic Injury Patterns in COVID-19: A Marker of Severity or Innocent Bystander?
Hemant Goyal et al.
GASTROENTEROLOGY (2021)
Emergence of a Novel SARS-CoV-2 Variant in Southern California
Wenjuan Zhang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus
Yangyang Cheng et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2021)
Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage
Pragya D. Yadav et al.
JOURNAL OF TRAVEL MEDICINE (2021)
Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19
Sarita Choudhary et al.
ANNALS OF LABORATORY MEDICINE (2021)
Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study
Rahul Parit et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Pharmacological management of COVID-19 in type 2 diabetes
Antonio Ceriello et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2021)
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Eric J. Haas et al.
LANCET (2021)
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
Kamlesh Khunti et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Severity of COVID-19 and Treatment Strategy for Patient With Diabetes
Shi Jin et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
Talia Kustin et al.
NATURE MEDICINE (2021)
A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel
Neta S. Zuckerman et al.
VACCINES (2021)
Acute pancreatitis in a patient with COVID-19
Rawan A. Rahman AlHarmi et al.
BMJ CASE REPORTS (2021)
BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B.1.1.7 in high-risk populations in Israel
Ariel Munitz et al.
CELL REPORTS MEDICINE (2021)
Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: A retrospective study from an academic center in Belgium
Laura Orioli et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)
Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan
Takahisa Fujino et al.
EMERGING INFECTIOUS DISEASES (2021)
Comprehensive in silico identification of impacts of ACE2 SNPs on COVID-19 susceptibility in different populations
Alireza Paniri et al.
GENE REPORTS (2021)
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Janis A. Mueller et al.
NATURE METABOLISM (2021)
Estimation of case-fatality rate in COVID-19 patients with hypertension and diabetes mellitus in the New York state: a preliminary report
Yang Ge et al.
EPIDEMIOLOGY AND INFECTION (2021)
Increased serum amylase and/or lipase in coronavirus disease 2019 (COVID-19) patients: Is it really pancreatic injury?
Rabbinu R. Pribadi et al.
JGH OPEN (2021)
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Soo Lim et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Haibo Zhang et al.
INTENSIVE CARE MEDICINE (2020)
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Hao Xu et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)
COVID-19 pandemic, coronaviruses, and diabetes mellitus
Ranganath Muniyappa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence
Krishna Sriram et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
Daniel Batlle et al.
CLINICAL SCIENCE (2020)
Patients with diabetes are at higher risk for severe illness from COVID-19
G. Targher et al.
DIABETES & METABOLISM (2020)
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
Yuchen Chen et al.
DIABETES CARE (2020)
The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan
Yang Zhang et al.
DIABETES OBESITY & METABOLISM (2020)
Why is hyperglycaemia worseningCOVID-19 and its prognosis?
Antonio Ceriello et al.
DIABETES OBESITY & METABOLISM (2020)
Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients withCOVID-19
Huiqing Li et al.
DIABETES OBESITY & METABOLISM (2020)
Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetes
Francesco Prattichizzo et al.
DIABETES OBESITY & METABOLISM (2020)
Diabetes is a risk factor for the progression and prognosis of COVID-19
Weina Guo et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2020)
Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia
Fan Wang et al.
GASTROENTEROLOGY (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Angiotensin-converting enzyme 2 (ACE2),SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)
Arno R. Bourgonje et al.
JOURNAL OF PATHOLOGY (2020)
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
Celestino Sardu et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
Yongli Yan et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies
Alessandro Mantovani et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
Type 1 diabetes onset triggered by COVID-19
Lucien Marchand et al.
ACTA DIABETOLOGICA (2020)
Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation
Jiawei Chen et al.
AGING CELL (2020)
Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?
Ivana Rabbone et al.
DIABETES CARE (2020)
Increased Hepatic ACE2 Expression in NAFL and Diabetes-A Risk for COVID-19 Patients?
Jelena Soldo et al.
DIABETES CARE (2020)
Characteristics and Diabetes Control in Adults With Type 1 Diabetes Admitted With COVID-19 Infection
Maria Vamvini et al.
DIABETES CARE (2020)
Diabetes and COVID-19: Global and regional perspectives
In-Kyung Jeong et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Comorbid diabetes and the risk of disease severitytrun or death among 8807 COVID-19 patients in China: A meta-analysis
Li Guo et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak?
Paola Caruso et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis
Rizwana Parveen et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Demographic and clinical features of critically ill patients with COVID-19 in Greece: The burden of diabetes and obesity
P. Halvatsiotis et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study
Sufei Wang et al.
DIABETOLOGIA (2020)
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Ines Valencia et al.
FRONTIERS IN PHARMACOLOGY (2020)
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
Naomi Holman et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
Emma Barron et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Gholamreza Daryabor et al.
FRONTIERS IN IMMUNOLOGY (2020)
Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany
Clemens Kamrath et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Interleukin-6 as a potential biomarker of COVID-19 progression
Zulvikar Syambani Ulhaq et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
LEClinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study
Irit Nachtigall et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes
Sara R. A. Wijnant et al.
DIABETES (2020)
Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy
Marco Mirani et al.
DIABETES CARE (2020)
COVID-19 and Children With Diabetes-Updates, Unknowns, and Next Steps: First, Do No Extrapolation
Linda A. DiMeglio et al.
DIABETES CARE (2020)
New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the UK
Rebecca Unsworth et al.
DIABETES CARE (2020)
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
Awadhesh Kumar Singh et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severeCOVID-19 in type 2 diabetes
Fawaz Alzaid et al.
EMBO MOLECULAR MEDICINE (2020)
COVID-19 and diabetes mellitus: how one pandemic worsens the other
William S. Azar et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)
Impact of glycemic control in diabetes mellitus on management of COVID-19 infection
Sudhir Bhandari et al.
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES (2020)
The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study
Lawrence Fisher et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2020)
SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease
Rajasree Menon et al.
KIDNEY INTERNATIONAL (2020)
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Andrew G. Harrison et al.
TRENDS IN IMMUNOLOGY (2020)
D-dimer level in COVID-19 infection: a systematic review
Mehrdad Rostami et al.
EXPERT REVIEW OF HEMATOLOGY (2020)
Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia
Wan Zhou et al.
JOURNAL OF DIABETES RESEARCH (2020)
A comparison of COVID-19, SARS and MERS
Tingting Hu et al.
PEERJ (2020)
Diabetes, infection risk and COVID-19
Suheda Erener
MOLECULAR METABOLISM (2020)
Prevalence and impact of diabetes in patients with COVID-19 in China
Min Du et al.
WORLD JOURNAL OF DIABETES (2020)
Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19
Irina Kusmartseva et al.
CELL METABOLISM (2020)
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells
Katie C. Coate et al.
CELL METABOLISM (2020)
Clock Genes, Inflammation and the Immune System-Implications for Diabetes, Obesity and Neurodegenerative Diseases
Elaine Vieira et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Thrombocytopenia and thrombosis in hospitalized patients with COVID-19
Heng Mei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes
Yujing Sun et al.
JOURNAL OF DIABETES RESEARCH (2020)
The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions
Habib Yaribeygi et al.
JOURNAL OF DIABETES RESEARCH (2020)
Impact of Diabetes in Patients Diagnosed With COVID-19
Mohamed Abu-Farha et al.
FRONTIERS IN IMMUNOLOGY (2020)
Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19
Mohammad Shafi Kuchay et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Relation of D-dimer levels of COVID-19 patients with diabetes mellitus
Yogendra Mishra et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Clinical characteristics of hospitalized and home isolated COVID-19 patients with type 1 diabetes
Ayman A. Al Hayek et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Acute pancreatic injury induced by COVID-19
R. Nikhil Kumar Patnaik et al.
IDCASES (2020)
Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence
Salman Hussain et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
New onset diabetes, type 1 diabetes and COVID-19
Sirisha Kusuma Boddu et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Deadly Companions: COVID-19 and Diabetes in Mexico
Merrill Singer
MEDICAL ANTHROPOLOGY (2020)
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
Ashish Kumar et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States
Bruce Bode et al.
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2020)
Diabetes in COVID-19: Prevalence, practical considerations
Awadhesh Kumar Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
COVID-19 and diabetes mellitus: An unholy interaction of two pandemics
Rimesh Pal et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Mortality Rate and Predictors of Mortality in Hospitalized COVID-19 Patients with Diabetes
Dilaram Acharya et al.
HEALTHCARE (2020)
Multi-Organ Failure in a Patient With Diabetes due to COVID-19 With Clear Lungs
Sohaip Kabashneh et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
Wentao Ni et al.
CRITICAL CARE (2020)
Vitamin D deficiency in patients with diabetes and COVID-19 infection
S. K. Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Type 2 Diabetes: How Much of an Autoimmune Disease?
Paola de Candia et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Ending diabetes in Mexico
Mathieu Levaillant et al.
LANCET (2019)
Definition, Classification and Diagnosis of Diabetes Mellitus
Astrid Petersmann et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2019)
Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection
Kirsten A. Kulcsar et al.
JCI INSIGHT (2019)
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Zubin Punthakee et al.
CANADIAN JOURNAL OF DIABETES (2018)
Complications of Diabetes 2017
Konstantinos Papatheodorou et al.
JOURNAL OF DIABETES RESEARCH (2018)
Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies
Raminderjit Kaur et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality
Lynnm. Frydrych et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Platelet Activation and Platelet-Leukocyte Aggregates in Type I Diabetes Mellitus
Asmaa M. Zahran et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
Role of Adaptive and Innate Immunity in Type 2 Diabetes Mellitus
Tong Zhou et al.
JOURNAL OF DIABETES RESEARCH (2018)
Prevalence of previously diagnosed diabetes mellitus in Mexico
Rosalba Rojas-Martinez et al.
SALUD PUBLICA DE MEXICO (2018)
The Association between Vitamin D Deficiency and Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis of Observational Studies
Bang-An Luo et al.
NUTRIENTS (2017)
Macrovascular Complications in Patients with Diabetes and Prediabetes
Dou Huang et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Diabetes microvascular complications-A clinical update
H. Khalil
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
Vitamin D deficiency and diabetes
Michael J. Berridge
BIOCHEMICAL JOURNAL (2017)
Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia
Gouri Rani Banik et al.
VIROLOGICA SINICA (2016)
Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections
Kelly Hodgson et al.
IMMUNOLOGY (2015)
Association of polymorphisms of angiotensin I converting enzyme 2 with retinopathy in type 2 diabetes mellitus among Chinese individuals
N. Meng et al.
EYE (2015)
Neurological Consequences of Diabetic Ketoacidosis at Initial Presentation of Type 1 Diabetes in a Prospective Cohort Study of Children
Fergus J. Cameron et al.
DIABETES CARE (2014)
The ACE2 gene: its potential as a functional candidate for cardiovascular disease
Louise M. Burrell et al.
CLINICAL SCIENCE (2013)
Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system
Robson A. S. Santos et al.
JOURNAL OF ENDOCRINOLOGY (2013)
ACE2-From the renin-angiotensin system to gut microbiota and malnutrition
Thomas Perlot et al.
MICROBES AND INFECTION (2013)
Association of ACE2 Genetic Variants With Blood Pressure, Left Ventricular Mass, and Cardiac Function in Caucasians With Type 2 Diabetes
Sheila K. Patel et al.
AMERICAN JOURNAL OF HYPERTENSION (2012)
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation
Tatsuo Hashimoto et al.
NATURE (2012)
Angiotensin-Converting Enzyme 2: The First Decade
Nicola E. Clarke et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2012)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Investigation of ACE, ACE2 and AGTR1 genes for association with nephropathy in Type 1 diabetes mellitus
D. Currie et al.
DIABETIC MEDICINE (2010)
Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls
Sonoo Mizuiri et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
Robson A. S. Santos et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Angiotensin-converting enzyme 2 in the brain: properties and future directions
Huijing Xia et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease
Heather N. Reich et al.
KIDNEY INTERNATIONAL (2008)
Comorbidity in patients with diabetes mellitus: impact on medical health care utilization
Jeroen N. Struijs et al.
BMC HEALTH SERVICES RESEARCH (2006)
Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathy
S Fröjdö et al.
DIABETOLOGIA (2005)
Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2)
KF To et al.
JOURNAL OF PATHOLOGY (2004)
Angiotensin-converting enzyme-2: a molecular and cellular perspective
FJ Warner et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy
C Tikellis et al.
HYPERTENSION (2003)
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
K Maedler et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets
K Maedler et al.
DIABETES (2001)